Paras Pharmaceuticals Sold Reckit |
The race to buy Paras Pharmaceuticals has entered the second leg, with its investment banker approaching at least five global drugmakers.
The deal to acquire Paras Pharmaceuticals, which owns brands such as Moov, D' Cold, Livon, is stuck on the pricing front as leading pharma majors like Dabur are in the fight to acqire.
More to that Reckitt Benckiser Set To Buy Paras - UK-based company Reckitt Benckiser is all set to buy Ahmedabad-based Paras Pharmaceuticals for Rs 3000-3500 crore.